The approval is based on findings from the phase 3, multicenter, open-label, randomized TROPION-Breast01 trial.
Scientists from A*STAR Genome Institute of Singapore (A*STAR GIS) have uncovered that a key enzyme—P4HA1 prolyl hydroxylase, ...